跳至主要内容
临床试验/NCT03477617
NCT03477617已完成不适用

A Single Centre Feasibility Randomized Controlled Trial of Advanced Minimally Invasive Monitoring to Optimize Hemodynamic Management in Major Noncardiac Surgery

University Health Network, Toronto2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2018年5月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
2
主要终点
Survey score on practicality of study algorithm (Intervention)

研究概览

简要总结

Serious complications occur in about 16% of major surgeries. Episode of hypotension during surgery may be a leading cause of these complications. Even though hypotension occurs frequently during surgery, choosing the correct treatment remains difficult in clinical practice. Physicians are often uncertain as to whether low blood pressure should be treated with intravenous fluid or vasoactive drugs. The first treatment of choice typically involves administering more intravenous fluid; however, excessive fluid administration during surgery has been shown to be deleterious. New minimally invasive hemodynamic monitors now offer a potential solution by guiding physicians with respect to the choice of appropriate intervention (i.e., fluid versus vasoactive drugs). The Investigators will conduct a single-center feasibility randomized control trial (RCT) at the Toronto General Hospital (Toronto, ON, Canada) of an algorithm to manage hypotension during surgery based on the information captured by a minimally invasive monitor. Sixty participants who are aged 40 years or older and scheduled to undergo an abdominal, pelvic or vascular surgery will be randomized to have the intraoperative hypotension managed by either the new algorithm (guided by the monitor) or usual care. Participants will be recruited over 12 to 18 months, and followed for 30 days to describe differences in clinical care, hemodynamics, complications, and death. The feasibility of a future multicenter RCT will be assessed based on this present study demonstrating that (1) the algorithm can be practically implemented in a clinical setting where hemodynamic monitors are not typically used; (2) initial descriptive data suggest differences in care between groups; (3) there are no obvious major harms from the protocol; and (4) there is an acceptable participation rate among eligible patients. These data will inform any required changes to the algorithm and protocol to allow for its application in a future study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥40 years
  • Abdominal, retroperitoneal, pelvic or vascular surgery requiring general anesthesia and planned postoperative stay of ≥48 hours for medical reasons
  • Elevated perioperative cardiovascular risk based on at least one of the following:
  • cardiovascular comorbidities: coronary artery disease, heart failure, cerebrovascular disease, or peripheral arterial disease
  • elevated age (≥70 y),
  • hypertension,
  • diabetes mellitus,
  • or preoperative estimated glomerular filtration rate ≤60mL/min/1.73m2
  • Planned placement of invasive arterial line for clinical care

排除标准

  • Preoperative dialysis dependence
  • Minimally invasive procedures (i.e., laparoscopic or endovascular approach)
  • Intra-thoracic procedures
  • Non-sinus rhythm
  • Liver resection surgery

结局指标

主要结局

Survey score on practicality of study algorithm (Intervention)

时间窗: 2 years

• Practicality of study algorithm will be measured by the survey scores of the anesthesiologists involved in the intraoperative care, assessing several domains using a 5 point Likert scale such as (1) Ease of use, (2) Clinical Utility, (3) Validity

Participation rate (Feasibility trial pre-RCT)

时间窗: 2 years

• Participation rate: The number of patients consented to the study over the number of eligible patients. This will help estimate recruitment rates in a future clinical randomized trial.

Incidence of treatment related Adverse Events

时间窗: 2 years

Number of participants with Adverse Events thought to be at least possibly related to the study treatment will be reported. This outcome will assure that no harm has resulted from the study protocol and the protocol is safe for a future randomized control trial

次要结局

  • Hypotension (blood pressure in mmHg) (therapeutic interventions) for each arm of the study(During intra-operative period and up to 72 hours after surgery.)
  • Volume of intravenous fluid and volume of blood products (therapeutic interventions) for each arm of the study.(During intra-operative period and recovery, an average of 12 hours.)
  • Dose of vasoactive medication (therapeutic interventions) for each arm of the study.(During intra-operative period and recovery, an average of 12 hours.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jo Carroll

Principal Investigator

University Health Network, Toronto

研究点 (2)

Loading locations...

相似试验